Best of Smartkarma: The Guest Editor's Slice & Dice #23
Welcome to the 23rd Edition of the Smartkarma [Guest] Editor's Cut, a weekly summary of the key themes and ideas of the last week's research on...
628 Views
Global Cord Blood (CO US): Fate Seems to Be Changing as New Growth Engine Added
Global Cord’s foray into a new line of business through the acquisition of a clinical-stage biotech company is expected to add a new growth engine...
666 Views
Global Cord Blood (CO US): Gloomy Regulatory and Business Environment Explain Cheap Valuation
Global Cord seems to be an undervalued business, however, regulatory uncertainty, decelerating subscribers addition, and declining birth rate in...
620 Views
Global Cord Blood (CO US): No Immediate Respite Is Seen
Global Cord Blood has rejected the acquisition offer from Alternate Ocean Investment. Shares are now trading 22% below the offer price of $5.00 per...
348 Views
Global Cord Blood (CO US): Overhangs Persist; Weak Q2 Results Adds to Woe
Global Cord reported muted Q2 results with revenue and new subscribers sign-ups remaining flat sequentially, representing slower recovery. Shares...
651 Views